Use of Progestogen Tied to Higher Chance of Benign Brain Tumor
Many people worldwide use progestogen-based hormonal contraception or hormone replacement therapy to manage menopause symptoms. Previous research has linked a handful of high-dose progestogens —cyproterone acetate, nomegestrol acetate, and chlormadinone acetate—with increased risk of meningiomas, a common type of brain tumor that is generally noncancerous.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research
More News: American Medical Association (AMA) | Brain | Brain Cancers | Brain Tumor | General Medicine | Hormone Replacement Therapy | Hormones | Men | Menopause | Neurology